Navigation Links
Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
Date:1/13/2009

BOSTON, Jan. 13 /PRNewswire/ -- Johnston Blakely & Company, LLC, a Boston-based life science investment bank, is pleased to announce that Michael D. Webb has joined the firm as senior advisor. In this role, Mr. Webb will participate with the firm on internal and client-related activities including merger & acquisition advisory services and private equity placements, with a particular focus on biopharmaceutical transactions. "We are delighted to have someone of Mike's caliber join the Johnston Blakely team," said Johnston Blakely founder Benjamin Conway. "His extensive senior management experience and depth of sector knowledge will be of tremendous value to both the firm and its clients."

Mr. Webb was previously President & CEO of EPIX Pharmaceuticals where he completed over $225 million in financings, including its 1997 IPO, and raised an additional $150 million through corporate partnerships. Prior to EPIX, Mr. Webb was Senior Vice President, Worldwide Marketing and Strategic Planning for Ciba Diagnostics. Most recently he has been active with Ascent Therapeutics where as founder, president & CEO he organized the company and secured its initial $20 million in venture financing. Mr. Webb holds an M.B.A. with highest honors from Northwestern University's Kellogg Graduate School of Management.

About Johnston Blakely & Company

Johnston Blakely & Company, LLC is a Boston-based investment bank offering merger & acquisition-related financial advisory and private equity placement services to companies in the life science sector. The firm incorporates the venture capital tradition of comprehensive company involvement into investment banking engagements to deliver superior results for its clients. More than investment banking...inVenture banking(TM).

Johnston Blakely is a registered broker/dealer and member of FINRA/SIPC.


'/>"/>
SOURCE Johnston Blakely & Company, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees
2. Bolder BioTechnology Receives $1.9 Million NIH Grant to Continue Development of Long-Acting Growth Hormone Product
3. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
4. Micromet Added to NASDAQ Biotechnology Index
5. Far From Beyond: A Glimpse into the World of Biotechnology and the Future of the Free World
6. North Carolinas Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
7. Yongye Biotechnology Announces Record Third Quarter Results
8. World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
9. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
10. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
11. InNexus Biotechnology Receives Patent Grants in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Global ... in-depth study on the current state of the Trifluoroacetic ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/27/2014)... 27, 2014  A novel biomarker for rheumatoid ... better identify early-stage disease, when treatment can often ... a new study in The Journal of Rheumatology. ... DGX ) and other institutions found that ... conventional antibody-serum testing, including rheumatoid factor (RF) and ...
(Date:8/27/2014)... Westminster, CO (PRWEB) August 27, 2014 ... image analysis services to the pharmaceutical and medical ... and expansion. The fast growing company has consolidated ... in Aurora and Boulder to Westminster, CO, just north ... and Histology Lab, 7575 W. 103rd Ave., Suite 100, ...
(Date:8/27/2014)... 2014 Tris Pharma, a specialty pharmaceutical company ... that it has been selected as an award winner ... 2014 Awards for Excellence competition in the Business ... of judges from SCORE (Counselors to America,s Small Business) ... honored at a gala event to be held on ...
Breaking Biology Technology:Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Flagship Biosciences Announces Relocation and Expansion 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2
... Pa., Aug. 24 MEDRAD, Inc. has signed a ... to study the impact of automated Fluoro-deoxy-glucose (FDG) administration ... procedures. Clinicians at Moffitt Cancer Center in Tampa, ... measure and infuse patient-specific FDG doses while industrial engineers ...
... , , SAN DIEGO, Aug. ... today announced that Mark Booth has joined the Company as ... of commercial and business development experience to Orexigen. Most ... (TPNA) where he presided over the commercial, medical and scientific ...
... , KVISTGAARD, Denmark, August ... that the US authorities have initiated,negotiations for a ... the,IMVAMUNE(R) smallpox vaccine. This potential new project will ... Advanced Research and,Development Authority) contract for the procurement ...
Cached Biology Technology:MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 2MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 4Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE(R) 2
(Date:8/27/2014)... getting effective doses of the HIV drug maraviroc, a ... studies, completed before the drug was licensed in 2007, ... is key to removing maraviroc from the body. The ... the protein including nearly half of African-Americans ... to those who lack the protein even when given ...
(Date:8/27/2014)... grass species frequently found in forests has created a ... American toads, a new University of Georgia study has ... the U.S. in the early 1900s, is one of ... more than a dozen states in the past century, ... in forests, it can survive in widely diverse ecosystems ...
(Date:8/27/2014)... what is described by the Volunteer Wildfire Services of ... Cape provincial government warned residents in certain parts of ... veld fires. A high veld fire danger rating ... coast in the Great Kei and Mnquma area. ... thunderstorms. The thunderstorms bring lightning strikes and subsequent ...
Breaking Biology News(10 mins):Dosage of HIV drug may be ineffective for half of African-Americans 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3
... great mysteries of life is how it began. What physical process ... a living cell? For more than a century, scientists have ... life. Until recently, their focus has been trained on how the ... early Earth, or perhaps in space. But because it happened so ...
... firing in a brain reward circuit instantly rendered mice ... a study supported by the National Institutes of Health ... mimic the pattern, previously resilient mice instantly succumbed to ... they avoided other animals and lost their sweet ...
... of Notre Dame biochemist Anthony S. Serianni is providing ... and treating diabetes. Serianni points out that biological ... human body from the natural breakdown of the simple ... in diabetic patients because glucose concentrations in the blood ...
Cached Biology News:ASU researchers propose new way to look at the dawn of life 2ASU researchers propose new way to look at the dawn of life 3Stress-resilience/susceptibility traced to neurons in reward circuit 2Stress-resilience/susceptibility traced to neurons in reward circuit 3Stress-resilience/susceptibility traced to neurons in reward circuit 4Notre Dame research may have important implications for combating diabetes 2
... centrifugal filters are disposable microfiltration devices for the ... the range 100 l to 500 l. They ... 2.2 ml centrifuge tubes. Product Features: ... Low hold up volume ( Fast ...
... The ClearSpin Filter is a novel disposable ... the clarification of bacterial lysates in plasmid ... is a novel, disposable spin filtration device ... bacterial lysates in plasmid purification procedures. The ...
... fixed-angle microcentrifuge rotor at RCF up ... filters consist of a membrane-containing filter ... filter by centrifugation for bacteria removal, ... of cells from media and DNA ...
... C, 0.7 mm depth • Reusable, press-to-seal ... be quickly assembled and disassembled for hybridizing ... of any thickness with up to a ... chambers per slide. Minimize specimen handling, eliminate ...
Biology Products: